STOKE THERAPEUTICS INC (STOK) Stock Balance Sheet
NASDAQ:STOK - Nasdaq - US86150R1077 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 127.98M | 191.44M | 113.60M | 144.90M | 287.30M | |||
| Marketable Securities | 88.92M | 9.95M | 116.00M | 74.90M | N/A | |||
| Receivables | 700.00K | 64.00K | 600.00K | 100.00K | 0.00 | |||
| Other Current Assets | 15.16M | 13.88M | 13.90M | 9.30M | 6.60M | |||
| Total Current Assets | 232.76M | 215.34M | 244.10M | 229.20M | 293.90M | |||
| Non-Current Assets | ||||||||
| PPE Net | 8.25M | 12.43M | 11.40M | 9.10M | 3.80M | |||
| Investments And Advances | 29.82M | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 721.00K | 569.00K | 600.00K | 600.00K | 200.00K | |||
| Total Non-Current Assets | 38.80M | 13.00M | 12.00M | 9.70M | 4.00M | |||
| TOTAL ASSETS | 271.56M | 228.34M | 256.10M | 238.90M | 297.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 17.81M | 12.96M | 15.20M | 14.20M | 8.50M | |||
| Accounts Payable | 2.50M | 1.70M | 800.00K | 2.40M | 1.50M | |||
| Other Current Liabilities | 19.74M | 16.17M | 15.40M | 500.00K | 1.40M | |||
| Total Current Liabilities | 40.06M | 30.82M | 31.40M | 17.10M | 11.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 2.48M | 37.96M | 39.80M | 3.90M | 400.00K | |||
| Total Non-Current Liabilities | 2.48M | 37.96M | 39.80M | 4.00M | 400.00K | |||
| TOTAL LIABILITIES | 42.53M | 68.78M | 71.20M | 21.10M | 11.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -490.83M | -401.85M | -297.20M | -196.10M | -110.30M | |||
| Additional Paid In Capital | 720.00M | 561.43M | 483.20M | 414.00M | 396.40M | |||
| Common Shares | 5.00K | 5.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -151.00K | -24.00K | -1.20M | -200.00K | N/A | |||
| Shares Outstanding | 54.03M | 45.92M | 39.40M | 36.90M | 36.60M | |||
| Tangible Book Value per Share | 4.24 | 3.48 | 4.69 | 5.90 | 7.82 | |||
| Total Shareholders' Equity | 229.02M | 159.56M | 184.80M | 217.80M | 286.10M | |||
| TOTAL LIABILITIES AND EQUITY | 271.56M | 228.34M | 256.10M | 238.90M | 297.90M | |||
| Statistics | ||||||||
| Current Ratio | 5.81 | 6.99 | 7.77 | 13.40 | 25.78 | |||
| Return On Assets (ROA) | -32.77% | -45.85% | -39.47% | -35.92% | -17.54% | |||
| Return On Equity (ROE) | -38.85% | -65.62% | -54.69% | -39.40% | -18.26% | |||
All data in USD , ROIC based on taxRate of 0.21